| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥310.2B | ¥338.4B | -8.3% |
| Operating Income | ¥26.2B | ¥20.9B | +25.5% |
| Ordinary Income | ¥26.2B | ¥19.3B | +36.0% |
| Net Income | ¥20.0B | ¥9.7B | +106.5% |
| ROE | 14.1% | 7.2% | - |
FY2025 Q3 (9-month cumulative) results showed revenue of 310.2B yen (YoY -8.3%) and operating income of 26.2B yen (YoY +25.5%), representing a revenue decline with profit improvement pattern. Ordinary income reached 26.2B yen (+36.0%) and net income 20.0B yen (+106.5%), more than doubling from the prior year. The operating margin expanded to 8.4% from 6.2% in the prior period, indicating successful profit rate improvement despite the top-line contraction. Basic EPS increased to 94.48 yen from 44.48 yen (+112.4%). Total assets decreased to 365.8B yen from 389.3B yen, while equity increased to 141.3B yen from 133.8B yen, resulting in an equity ratio of 38.6%. ROE reached 14.1%, substantially exceeding the company's recent performance levels.
Revenue declined by 8.3% to 310.2B yen, driven primarily by external sales contraction across all geographic segments. Japan segment external sales decreased slightly to 133.9B yen from 133.0B yen, Asia segment declined to 50.5B yen from 54.1B yen (-6.6%), North and Central America contracted significantly to 93.2B yen from 114.2B yen (-18.4%), and Europe decreased to 32.6B yen from 37.1B yen (-12.1%). The North and Central America region showed the most pronounced decline, suggesting potential demand weakness or market share loss in that geography. Inter-segment sales also decreased to 150.9B yen from 167.1B yen, indicating reduced internal transactions.
Despite revenue contraction, profitability improved markedly. Gross profit of 77.8B yen yielded a gross margin of 25.1%, maintaining stable product profitability. SG&A expenses totaled 51.6B yen, representing 16.6% of revenue, down from approximately 19.7% in the prior period based on operating margin improvement. This SG&A leverage contributed significantly to operating income expansion to 26.2B yen from 20.9B yen (+25.5%). The operating margin of 8.4% represents a 2.2 percentage point improvement YoY.
At the ordinary income level, non-operating factors added approximately 0.03B yen net benefit (ordinary income 26.2B yen versus operating income 26.2B yen). Foreign exchange gains of 0.15B yen provided support, while interest expenses of 0.20B yen represented a manageable cost of debt. Net income surged 106.5% to 20.0B yen, benefiting from the improved operating base and an effective tax rate that resulted in tax expenses of 6.2B yen on pre-tax income of 26.2B yen (approximately 24% rate).
The company achieved a revenue down, profit up pattern, driven by margin expansion through cost control and operational efficiency improvements, offsetting the negative volume effect from sales decline. No material extraordinary items were disclosed in the impairment information section.
Asia segment generated revenue of 182.3B yen (including inter-segment sales) with operating income of 15.1B yen, representing an operating margin of 8.3%. This was the largest segment by total sales, though Japan held the largest external sales position. Japan segment recorded revenue of 146.2B yen with operating income of 7.4B yen (margin: 5.1%), serving as a core domestic business base with relatively lower profitability. North and Central America segment showed revenue of 93.7B yen with operating income of 2.1B yen (margin: 2.2%), reflecting the weakest profitability among regions and suggesting competitive or cost pressures in this market. Europe segment reported revenue of 39.0B yen with operating income of 2.3B yen (margin: 5.9%), demonstrating mid-level profitability.
The Asia segment exhibited the highest operating margin at 8.3%, significantly exceeding other regions, which indicates this segment represents the most profitable geography and likely serves as the core manufacturing or sourcing base given its high inter-segment sales. Japan's 5.1% margin suggests mature market characteristics with competitive intensity. North and Central America's compressed 2.2% margin warrants attention as a potential area for operational improvement or strategic review. All segments achieved profitability, with Asia contributing approximately 56% of total segment operating profit, establishing it as the primary profit driver.
[Profitability] ROE of 14.1% substantially exceeds the company's historical levels and represents strong return on shareholder equity. Operating margin of 8.4% improved 2.2 percentage points from 6.2% YoY, reflecting successful cost management. Net profit margin reached 6.4%, up from approximately 2.9% in the prior period, indicating improved bottom-line efficiency. Gross margin of 25.1% remained stable, demonstrating maintained pricing power or favorable product mix. [Cash Quality] Cash and deposits totaled 65.3B yen against short-term borrowings of 153.5B yen, resulting in a cash-to-short-term debt coverage ratio of 0.43x, indicating limited immediate liquidity buffer. Current assets of 271.9B yen provide broader liquidity resources. [Investment Efficiency] Asset turnover of 0.85x (annualized revenue of 310.2B divided by average assets) demonstrates moderate asset utilization. Inventory of 55.4B yen represents approximately 60 days of revenue, suggesting potential inventory accumulation. [Financial Health] Equity ratio of 38.6% improved from 34.4% in the prior period, indicating strengthened financial stability. Current ratio of 129.3% (271.9B current assets / 210.4B current liabilities) meets basic liquidity standards. Financial leverage of 2.59x contributes to ROE amplification while remaining at manageable levels.
Cash and deposits increased to 65.3B yen from prior period levels, though the absolute prior figure is not specified. The balance sheet shows working capital dynamics with inventories at 55.4B yen and current liabilities at 210.4B yen, indicating working capital absorption. Accounts payable decreased substantially by 11.9B yen to 22.0B yen from 33.9B yen (-35.2%), suggesting accelerated supplier payments or tightened payment terms that consumed cash resources. This payables reduction represents a significant use of liquidity. With net income of 20.0B yen generated during the nine-month period and retained earnings increasing by 18.4B yen to 84.1B yen, profit accumulation contributed positively to equity. However, the cash-to-short-term debt ratio of 0.43x indicates that cash generation has not been sufficient to significantly reduce reliance on short-term borrowings of 153.5B yen. The working capital metrics show inventory days of 183 and receivables days of 83, totaling 266 days of capital tied up, while payables days decreased, resulting in an extended cash conversion cycle that places pressure on liquidity. Current assets coverage of current liabilities at 129.3% provides basic solvency, though the composition shows heavy reliance on operating assets rather than liquid cash. The balance sheet changes suggest operating profit growth has been partially offset by working capital demands and debt service obligations.
Ordinary income of 26.2B yen versus operating income of 26.2B yen shows minimal non-operating impact, indicating earnings are primarily driven by core business operations. Non-operating income composition includes foreign exchange gains of 0.15B yen as a modest positive contributor, representing approximately 0.5% of operating income. Interest expenses of 0.20B yen reflect financing costs on debt and result in an interest coverage ratio of 12.9x (operating income 26.2B / interest 0.20B), demonstrating strong debt service capacity from operations. Non-operating items net to approximately zero impact, suggesting that ordinary income quality closely tracks operating performance without material distortion from financial activities. The absence of disclosed operating cash flow data limits the ability to assess earnings quality through cash conversion metrics. However, the working capital deterioration evidenced by extended inventory days (183 days vs. industry median of 112 days) and receivables days (83 days vs. industry median of 85 days), combined with compressed payables days, suggests potential concerns about the cash-backing of reported profits. The 106.5% increase in net income substantially outpaced the 25.5% operating income growth, primarily attributable to tax effects and prior period comparison bases rather than one-time gains, as no extraordinary items are disclosed. Core earnings quality appears sound based on operating metrics, though working capital management and cash generation warrant monitoring.
Full-year revenue guidance of 400.0B yen implies Q4 revenue of approximately 89.8B yen. Nine-month actual revenue of 310.2B yen represents 77.6% progress against the full-year target, lagging the standard 75% benchmark by 2.6 percentage points, indicating slightly ahead-of-pace performance. Operating income of 26.2B yen represents 163.8% of the full-year guidance of 16.0B yen, significantly exceeding expectations and suggesting substantial guidance conservatism or unexpected profit improvement. This over-achievement by 63.8 percentage points at the nine-month mark indicates either guidance will be revised upward or Q4 will experience substantial profit decline. Ordinary income of 26.2B yen exceeds the full-year guidance of 13.0B yen by 101.5%, further confirming the disconnect between actual performance and forecast. The full-year revenue guidance implies YoY decline of 10.7% and operating income decline of 7.5% from what appears to be a prior full-year base, suggesting management anticipated more challenging conditions than currently materializing. EPS forecast of 9.46 yen appears significantly understated given nine-month actual EPS of 94.48 yen, indicating possible disclosure inconsistency or significant anticipated Q4 adjustments. The substantial outperformance against guidance across all profit metrics suggests management's forecasts were established with conservative assumptions that have not materialized, potentially related to demand expectations, cost assumptions, or timing of expenses now delayed into Q4.
Annual dividend forecast of 7.50 yen per share represents the planned shareholder distribution. Based on the nine-month EPS of 94.48 yen, if annualized proportionally, the implied full-year EPS would approximate 126 yen, resulting in a payout ratio of approximately 6.0%. However, using the company's own full-year EPS forecast of 9.46 yen yields a payout ratio of 79.3%, suggesting significant expected earnings decline in Q4 or potential forecast inconsistency. Given the actual net income of 20.0B yen for nine months and outstanding shares of 21,152K (average), the 7.50 yen dividend represents approximately 1.6B yen in total dividends based on shares outstanding, equating to an 8.0% payout ratio against nine-month net income annualized. The conservative payout ratio indicates management is retaining substantial earnings for reinvestment or balance sheet strengthening. No share buyback activity is disclosed in the available data. The total return ratio equals the payout ratio in the absence of buybacks, remaining at conservative levels that prioritize financial flexibility over aggressive shareholder returns. The dividend policy appears sustainable given current profitability and cash generation, though the lack of disclosed operating cash flow limits assessment of dividend coverage from a cash perspective.
Geographic concentration risk in North and Central America, where revenue declined 18.4% YoY to 93.2B yen, represents approximately 30% of total external sales, and this region shows the weakest operating margin at 2.2%. Continued deterioration in this market could materially impact consolidated profitability and suggests vulnerability to regional economic conditions or competitive dynamics.
Working capital management risk evidenced by inventory days of 183 (vs. industry median 112) and cash conversion cycle of 232 days indicates substantial capital tied up in operations. The 35.2% decline in accounts payable to 22.0B yen further pressures working capital, suggesting potential supplier relationship changes or credit term tightening that reduces financial flexibility. Extended inventory turnover suggests demand-supply mismatches or product obsolescence risk.
Liquidity and refinancing risk stemming from short-term borrowings of 153.5B yen against cash of 65.3B yen creates a 0.43x coverage ratio, substantially below prudent levels. With 100% of debt classified as current liabilities, the company faces concentrated maturity exposure requiring successful rollover of short-term facilities. Rising interest rates or tightening credit conditions could materially impact financing costs and availability, particularly given the current rate environment.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 14.1% significantly exceeds the industry median of 5.8% for manufacturing companies in 2025-Q3, positioning the company in the upper quartile of peer performance and indicating superior capital efficiency. Net profit margin of 6.4% aligns closely with the industry median of 6.5%, suggesting typical bottom-line conversion for the sector. Operating margin of 8.4% falls below the industry median of 8.9%, indicating room for operational efficiency improvement relative to peers despite recent margin gains.
Financial Health: Equity ratio of 38.6% falls substantially below the industry median of 63.8%, positioning the company in the lower quartile for financial stability and indicating higher financial leverage than typical for the manufacturing sector. Current ratio of 129.3% significantly underperforms the industry median of 287%, reflecting tighter liquidity management and higher reliance on short-term funding relative to sector norms.
Efficiency: Asset turnover of 0.85x exceeds the industry median of 0.56x, demonstrating superior asset utilization and suggesting effective deployment of capital resources. However, inventory turnover of 183 days substantially exceeds the industry median of 112 days, indicating weaker inventory management efficiency. Receivables turnover of 83 days approximates the industry median of 85 days, showing typical collection performance. Operating working capital turnover of 232 days (calculated cash conversion cycle) significantly exceeds the industry median of 112 days, confirming working capital efficiency as a relative weakness.
Growth: Revenue decline of 8.3% underperforms the industry median growth of 2.8%, placing the company below peer growth trajectories. EPS growth of 112.4% substantially exceeds the industry median of 9%, driven by margin expansion despite revenue contraction, though this may reflect prior year comparison base effects.
Financial Leverage: Financial leverage of 2.59x exceeds the industry median of 1.53x, indicating higher debt utilization that amplifies both returns and risks relative to sector peers.
Industry: Manufacturing Sector (105 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis
Margin expansion capability demonstrated through 2.2 percentage point operating margin improvement to 8.4% despite 8.3% revenue decline indicates effective cost management and operational leverage. The company achieved this through SG&A expense control, reducing the cost ratio from approximately 19.7% to 16.6% of revenue, while maintaining stable gross margins at 25.1%. This profitability improvement drove ROE to 14.1%, substantially exceeding both company historical performance and the manufacturing industry median of 5.8%, positioning the company as an above-average profit generator. However, operating margin of 8.4% still trails the industry median of 8.9%, suggesting further efficiency opportunities exist. The profit rate improvement demonstrates management's ability to adapt cost structures to volume changes, though sustainability depends on maintaining these efficiency gains if revenue recovers.
Working capital and liquidity management present material concerns requiring monitoring. Inventory days of 183 substantially exceed the industry median of 112 days, receivables turnover of 83 days aligns with sector norms, but payables decreased 35.2% to compress working capital flexibility. The resulting cash conversion cycle of 232 days doubles the industry median of 112 days, indicating significant capital inefficiency. Short-term borrowings of 153.5B yen against cash of 65.3B yen create a 0.43x coverage ratio with 100% debt maturity concentration in current liabilities, substantially below the industry current ratio median of 287%. This liquidity structure creates refinancing risk and limits financial flexibility. The company's equity ratio of 38.6% falls well below the industry median of 63.8%, while financial leverage of 2.59x exceeds the sector median of 1.53x, confirming higher financial risk positioning than typical manufacturing peers. Interest coverage of 12.9x provides adequate debt service capacity from current operations, but working capital deterioration and refinancing concentration warrant close attention in monitoring credit risk and operational cash generation.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.